Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
589.56
418.73
687.72
719.19
715.10
610.57
1,248.35
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
589.56
418.73
687.72
719.19
715.10
610.57
1,248.35
Raw Material Cost
325.56
287.61
221.00
263.59
182.66
164.76
215.18
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
78.62
129.97
101.65
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
117.94
125.77
109.71
99.72
65.35
94.50
48.42
Selling and Distribution Expenses
187.59
327.85
481.90
582.44
941.02
760.61
732.94
Other Expenses
-4.33
1.82
2.74
-1.43
-1.85
-5.25
-6.26
Total Expenditure (Excl Depreciation)
587.74
759.38
840.06
931.45
1,249.15
1,097.33
1,035.53
Operating Profit (PBDIT) excl Other Income
1.7999999999999998
-340.7
-152.3
-212.3
-534.0999999999999
-486.8
212.8
Other Income
70.97
33.72
16.38
452.72
17.89
75.64
66.02
Operating Profit (PBDIT)
180.63
-189.11
-25.87
350.03
-427.49
-315.83
374.49
Interest
117.94
125.77
109.71
99.72
65.35
94.50
48.42
Exceptional Items
-82.37
-44.51
-88.36
-92.38
-4.28
-375.45
-558.94
Gross Profit (PBDT)
264.00
131.12
466.72
455.60
532.43
445.81
1,033.17
Depreciation
143.85
154.92
141.67
138.70
108.68
105.55
100.85
Profit Before Tax
-163.53
-514.30
-365.60
19.23
-605.81
-891.32
-333.73
Tax
17.68
4.34
-0.27
5.24
21.06
-6.53
7.05
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-173.65
-513.88
-370.55
30.81
-609.43
-884.77
-340.78
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-173.65
-513.88
-370.55
30.81
-609.43
-884.77
-340.78
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-6.44
-1.57
-2.00
-2.37
0.13
-0.02
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-180.09
-515.44
-372.55
28.44
-609.30
-884.79
-340.78
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
578.63
758.80
1,270.64
1,584.66
1,637.57
2,228.21
3,391.68
Earnings per share (EPS)
-0.2
-0.58
-0.42
0.03
-0.69
-0.96
-0.37
Diluted Earnings per share
-0.2
-0.58
-0.42
0.03
-0.69
-0.96
-0.37
Operating Profit Margin (Excl OI)
-5.8%
-90.21%
-26.74%
-33.56%
-77.48%
-81.4%
16.63%
Gross Profit Margin
-3.34%
-85.83%
-32.56%
21.96%
-69.52%
-128.69%
-18.65%
PAT Margin
-29.45%
-122.72%
-53.88%
4.28%
-85.22%
-144.91%
-27.3%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 40.82% vs -39.12% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 65.06% vs -38.36% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 149.24% vs -427.96% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -6.28% vs 14.68% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Hybio Pharmaceutical Co.. Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
589.56
0
589.56
Other Operating Income
0.00
0.00
0.00
Total Operating income
589.56
0
589.56
Raw Material Cost
325.56
0
325.56
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
117.94
0
117.94
Selling and Distribution Expenses
187.59
0
187.59
Other Expenses
-4.33
0.00
-4.33
Total Expenditure (Excl Depreciation)
587.74
0
587.74
Operating Profit (PBDIT) excl Other Income
1.82
0.00
1.82
Other Income
70.97
0
70.97
Operating Profit (PBDIT)
180.63
0
180.63
Interest
117.94
0
117.94
Exceptional Items
-82.37
0
-82.37
Gross Profit (PBDT)
264.00
0
264.00
Depreciation
143.85
0
143.85
Profit Before Tax
-163.53
0
-163.53
Tax
17.68
0
17.68
Provisions and contingencies
0
0
0.00
Profit After Tax
-173.65
0
-173.65
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-173.65
0
-173.65
Share in Profit of Associates
0
0
0.00
Minority Interest
-6.44
0
-6.44
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-180.09
0
-180.09
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
578.63
0
578.63
Earnings per share (EPS)
-0.20
0
-0.20
Diluted Earnings per share
-0.20
0
-0.20
Operating Profit Margin (Excl OI)
-5.80%
0%
0.00
-5.80%
Gross Profit Margin
-3.34%
0%
0.00
-3.34%
PAT Margin
-29.45%
0%
0.00
-29.45%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 58.96 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 40.82% vs -39.12% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -18.01 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 65.06% vs -38.36% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.97 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 149.24% vs -427.96% in Dec 2023
Annual - Interest
Interest 11.79 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -6.28% vs 14.68% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -5.80%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
